Our CEO was a featured panelist for the session From Data to Delivery, which was a key highlight of the conference at Track 2 (Clinical Data Management). During the session, he captivated the audience with his in-depth exploration of how AI is transforming the study closeout process by accelerating timelines, ensuring data integrity, and maintaining compliance. His insights into how intelligent workflows are driving efficiency, simplifying audits, and optimizing the entire clinical trial lifecycle resonated deeply with the audience, reflecting the growing impact of AI in clinical trials. Attendees were highly engaged during the session, actively participating in discussions and posing thought-provoking questions.